Brooks Laboratories Ltd

  • BSE Code : 533543
  • NSE Symbol : BROOKS
  • ISIN : INE650L01011
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 44.53 7.42(19.99%)

Open Price ()

38.98

Prev. Close ()

37.11

Volume (No’s)

83,311

Market Cap ()

109.32

Low Price ()

38.98

High Price ()

44.53

 

Book Closure

From Date To Date Announcement
06-Feb-2026 NA Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025 along with Limited Review Report issued by the Statutory Auditors of the Company thereon. Outcome of the Board Meeting held on Friday, 6th February 2026. (As Per BSE Announcement Dated on: 06/02/2026)
14-Nov-2025 NA Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2025 along with Limited Review Report of the Statutory Auditors of the Company thereon. Outcome of the Board Meeting held on Friday, 14th November 2025. (As per BSE Announcement dated on: 14.11.2025)
26-Sep-2025 NA AGM 26/09/2025 Notice of 23rd Annual General Meeting of the Company to be held on Friday, 26th September 2025 at 9:00 A.M through VC/OAVM. Pursuant to Regulation 30 of SEBI (LODR) 2015, please find enclosed herewith a summary of the proceedings of the 23rd AGM. (As Per BSE Announcement Dated on:26.09.2025) Scrutinizer Report along with voting results for the AGM held on September 26, 2025 (As per BSE Announcement dated on: 27/09/2025)
20-Sep-2025 26-Sep-2025 The Register of Members and Share Transfer Books will remain closed from Saturday, 20th September, 2025, to Friday, 26th September, 2025 (both days inclusive).
13-Aug-2025 NA Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of The Company for the Quarter Ended June 30 2025. Unaudited Financial Results and Limited Review for the quarter ended June 30, 2025 (As Per BSE Announcement Dated on: 13.08.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew